SBI Pharmaceuticals Co, Ltd.   Report issue

For profit
Founded: Tokyo Japan (2008)
Status: No NME R&D (2008)

Organization Overview

First Clinical Trial
2012
NCT01610778
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2014

Timeline

NOW
  • Now

Active Ingredients

Drugs in Other Trials (1)

aminolevulinic acid (levulan) (2 trials)

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 2
  • # of Trial APIs: 1